433 related articles for article (PubMed ID: 25262319)
1. The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome.
Kim DH; Yoon KC; Seo KY; Lee HS; Yoon SC; Sotozono C; Ueta M; Kim MK
Ophthalmology; 2015 Feb; 122(2):254-64. PubMed ID: 25262319
[TBL] [Abstract][Full Text] [Related]
2. Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome.
Kim KH; Park SW; Kim MK; Wee WR
Korean J Ophthalmol; 2013 Oct; 27(5):331-40. PubMed ID: 24082770
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Role of Amniotic Membrane Transplantation in Acute Ocular Stevens-Johnson Syndrome: A Randomized Control Trial.
Sharma N; Thenarasun SA; Kaur M; Pushker N; Khanna N; Agarwal T; Vajpayee RB
Ophthalmology; 2016 Mar; 123(3):484-91. PubMed ID: 26686968
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
5. Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Papakostas TD; Le HG; Chodosh J; Jacobs DS
Ophthalmology; 2015 Feb; 122(2):248-53. PubMed ID: 25282251
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children.
Lam NS; Yang YH; Wang LC; Lin YT; Chiang BL
J Microbiol Immunol Infect; 2004 Dec; 37(6):366-70. PubMed ID: 15599469
[TBL] [Abstract][Full Text] [Related]
7. Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson syndrome or toxic epidermal necrolysis.
Sotozono C; Yamauchi N; Maeda S; Kinoshita S
Am J Ophthalmol; 2014 Nov; 158(5):983-93. PubMed ID: 25036881
[TBL] [Abstract][Full Text] [Related]
8. Indications and outcomes of amniotic membrane transplantation in the management of acute stevens-johnson syndrome and toxic epidermal necrolysis: a case-control study.
Hsu M; Jayaram A; Verner R; Lin A; Bouchard C
Cornea; 2012 Dec; 31(12):1394-402. PubMed ID: 23135531
[TBL] [Abstract][Full Text] [Related]
9. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
Chen J; Wang B; Zeng Y; Xu H
Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset.
Araki Y; Sotozono C; Inatomi T; Ueta M; Yokoi N; Ueda E; Kishimoto S; Kinoshita S
Am J Ophthalmol; 2009 Jun; 147(6):1004-11, 1011.e1. PubMed ID: 19285657
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Effect of a Treatment Protocol for Acute Ocular Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Shanbhag SS; Rashad R; Chodosh J; Saeed HN
Am J Ophthalmol; 2019 Dec; 208():331-341. PubMed ID: 31326519
[TBL] [Abstract][Full Text] [Related]
13. The effects of systemic cyclosporine in acute Stevens-Johnson syndrome/toxic epidermal necrolysis on ocular disease.
Hall LN; Shanbhag SS; Rashad R; Chodosh J; Saeed HN
Ocul Surf; 2021 Jan; 19():128-132. PubMed ID: 32445836
[TBL] [Abstract][Full Text] [Related]
14. Early treatment with nonsucrose intravenous immunoglobulin in a burn unit reduces toxic epidermal necrolysis mortality.
Aires DJ; Fraga G; Korentager R; Richie CP; Aggarwal S; Wick J; Liu DY
J Drugs Dermatol; 2013 Jun; 12(6):679-84. PubMed ID: 23839186
[TBL] [Abstract][Full Text] [Related]
15. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
[TBL] [Abstract][Full Text] [Related]
16. Corneal Limbal Stem Cell Deficiency in Children with Stevens-Johnson Syndrome.
Choi SH; Kim MK; Oh JY
Am J Ophthalmol; 2019 Mar; 199():1-8. PubMed ID: 30347185
[TBL] [Abstract][Full Text] [Related]
17. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
Tan SK; Tay YK
Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
[TBL] [Abstract][Full Text] [Related]
18. Severity of acute ocular involvement is independently associated with time to resolution of ocular disease in toxic epidermal necrolysis patients.
Heng JS; Malik N; Joshi N; Hayes M; Jones I; Fuller LC; Vizcaychipi MP
Br J Ophthalmol; 2015 Feb; 99(2):251-4. PubMed ID: 25138767
[TBL] [Abstract][Full Text] [Related]
19. The relation between visual performance and clinical ocular manifestations in Stevens-Johnson syndrome.
Kaido M; Yamada M; Sotozono C; Kinoshita S; Shimazaki J; Tagawa Y; Hara Y; Chikama T; Tsubota K
Am J Ophthalmol; 2012 Sep; 154(3):499-511.e1. PubMed ID: 22818907
[TBL] [Abstract][Full Text] [Related]
20. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
De Rojas MV; Dart JK; Saw VP
Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]